Technical Analysis for SPRB - Spruce Biosciences, Inc.

Grade Last Price % Change Price Change
F 21.46 2.78% 0.58
SPRB closed up 2.78 percent on Wednesday, February 24, 2021, on 26 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical SPRB trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 2.78%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.78%
Stochastic Buy Signal Bullish 2.78%
Pocket Pivot Bullish Swing Setup 2.78%
Older End-of-Day Signals for SPRB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance about 6 hours ago
Up 5% about 6 hours ago
Rose Above 50 DMA about 6 hours ago
Rose Above Previous Day's High about 6 hours ago
Up 3% about 6 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Anatomy Hyperplasia Endocrine Disorders Adrenal Gland Disorders Congenital Adrenal Hyperplasia Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences

Is SPRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.6
52 Week Low 15.14
Average Volume 65,672
200-Day Moving Average 0.00
50-Day Moving Average 21.81
20-Day Moving Average 20.92
10-Day Moving Average 20.70
Average True Range 1.57
ADX 11.4
+DI 25.55
-DI 20.25
Chandelier Exit (Long, 3 ATRs ) 19.60
Chandelier Exit (Short, 3 ATRs ) 23.30
Upper Bollinger Band 22.99
Lower Bollinger Band 18.86
Percent B (%b) 0.63
BandWidth 19.72
MACD Line -0.39
MACD Signal Line -0.42
MACD Histogram 0.0354
Fundamentals Value
Market Cap 498.17 Million
Num Shares 23.2 Million
EPS
Price-to-Sales 0.00
Price-to-Book 21.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.61
Resistance 3 (R3) 23.61 22.89 23.25
Resistance 2 (R2) 22.89 22.35 22.89 23.13
Resistance 1 (R1) 22.18 22.01 22.54 22.18 23.01
Pivot Point 21.46 21.46 21.64 21.46 21.46
Support 1 (S1) 20.75 20.92 21.11 20.75 19.91
Support 2 (S2) 20.03 20.58 20.03 19.79
Support 3 (S3) 19.32 20.03 19.67
Support 4 (S4) 19.32